Kifunensine 10MG, CAT # BML-S114, quote # KW020112B, (25EA X $375.00 = $9,375.00)

Ended Awarded

Contract number
HHSN27200013
Awardee
Awarding agency
Obligated
$9,375

Award facts

Contract value 50% obligated
  • $9,375.00 Current, with exercised options
  • $18,750.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325199 All Other Basic Organic Chemical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Plymouth Meeting, PA 19462, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This is a firm fixed-price BPA call order issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Enzo Life Sciences International, Inc., a child company of Enzo Biochem, Inc. The contract is for the procurement of 25 units of the product KIFUNENSINE 10MG, with a ceiling value of $18,750.00. The award date is March 1, 2012, and the ultimate completion date is March 31, 2012. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract HHSN27200013?

HHSN27200013 was awarded to Enzo Life Sciences International, Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on March 1, 2012.

How much is contract HHSN27200013 worth?

The government has obligated $9,375 on HHSN27200013. Its potential value, with all options, is $18,750.

Is contract HHSN27200013 an order under another contract?

Yes. HHSN27200013 is a BPA call under HHSN263200400060800B, a blanket purchase agreement.

Was contract HHSN27200013 competed?

The extent of competition for HHSN27200013 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login